Cite
Exome variant prioritization in a large cohort of hearing-impaired individuals indicates IKZF2 to be associated with non-syndromic hearing loss and guides future research of unsolved cases.
MLA
Velde, Hedwig M., et al. “Exome Variant Prioritization in a Large Cohort of Hearing-Impaired Individuals Indicates IKZF2 to Be Associated with Non-Syndromic Hearing Loss and Guides Future Research of Unsolved Cases.” Human Genetics, vol. 143, no. 11, Nov. 2024, pp. 1379–99. EBSCOhost, https://doi.org/10.1007/s00439-024-02706-w.
APA
Velde, H. M., Vaseghi-Shanjani, M., Smits, J. J., Ramakrishnan, G., Oostrik, J., Wesdorp, M., Astuti, G., Yntema, H. G., Hoefsloot, L., Lanting, C. P., Huynen, M. A., Lehman, A., Turvey, S. E., Pennings, R. J. E., & Kremer, H. (2024). Exome variant prioritization in a large cohort of hearing-impaired individuals indicates IKZF2 to be associated with non-syndromic hearing loss and guides future research of unsolved cases. Human Genetics, 143(11), 1379–1399. https://doi.org/10.1007/s00439-024-02706-w
Chicago
Velde, Hedwig M, Maryam Vaseghi-Shanjani, Jeroen J Smits, Gayatri Ramakrishnan, Jaap Oostrik, Mieke Wesdorp, Galuh Astuti, et al. 2024. “Exome Variant Prioritization in a Large Cohort of Hearing-Impaired Individuals Indicates IKZF2 to Be Associated with Non-Syndromic Hearing Loss and Guides Future Research of Unsolved Cases.” Human Genetics 143 (11): 1379–99. doi:10.1007/s00439-024-02706-w.